SiliconInvestor
     Advanced Search   [ sign in ]

register
Register

 Biotech / Medical : ImmunoGen

 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
To: Gary Mohilner who wrote (5473)2/3/2012 2:09:55 PM
From: rjk01Read Replies (1) of 5530
 
he also added in response to unrelated q
provocateur - I like folate receptor very much as a target. IMGN’s ADC is much more potent and has far better PK properties than ECYT’s SMDC. In addition, it employs a new linker designed to counteract MDR effect.

Ohad
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.